TY  - JOUR
T1  - HIv trial modification
AU  - Friedrich MJ
Y1  - 2012/01/18
N1  - 10.1001/jama.2011.1976
JO  - JAMA
SP  - 243
EP  - 243
VL  - 307
IS  - 3
N2  - 
Based on the recommendations of the independent data and safety monitoring board (DSMB) of the Vaginal and Oral Interventions to Control the Epidemic (VOICE) study, the investigators will discontinue the section of the trial that involved participants receiving the tenofovir or placebo gels but will continue with a group who is receiving a pill containing 2 drugs (tenofovir and another anti-HIV drug, emtricitabine) or placebo.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2011.1976
UR  - http://dx.doi.org/10.1001/jama.2011.1976
ER  -